QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 eli-lilly-to-support-whos-international-dementia-action-plan-under-signed-collaboration

BERLIN, Oct. 13, 2025 /PRNewswire/ -- The WHO Foundation and Lilly have announced a collaboration to financially support the ai...

 eli-lilly-to-present-new-data-across-oncology-portfolio-at-esmo-2025-highlighting-verzenio-and-emerging-cancer-therapies

Eli Lilly and Company (NYSE:LLY) today announced that new data from across its oncology portfolio and pipeline will be presente...

 bill-gates-and-paho-push-to-make-weight-loss-drugs-accessible-in-low-income-nations

Bill Gates and PAHO are working to make weight-loss drugs like Wegovy and Mounjaro more affordable for low-income countries.

 guggenheim-maintains-buy-on-eli-lilly-raises-price-target-to-948

Guggenheim analyst Seamus Fernandez maintains Eli Lilly (NYSE:LLY) with a Buy and raises the price target from $875 to $948.

 peter-marks-fda-vaccine-regulator-ousted-by-rfk-jr-joins-eli-lilly-marks-will-lead-molecule-discovery-and-infectious-diseases---stat-news

https://www.statnews.com/2025/10/07/peter-marks-former-fda-vaccine-official-joins-eli-lilly/

 long-term-study-shows-sustained-remission-with-eli-lillys-ulcerative-colitis-drug

Eli Lilly's four-year LUCENT-3 study shows Omvoh maintained high remission rates and a consistent safety profile in ulcerat...

 eli-lillys-new-data-showed-omvoh-mirikizumab-mrkz-achieves-sustained-long-term-outcomes-through-four-years-in-ulcerative-colitis-patients

Approximately 80% of Omvoh-treated patients in the LUCENT-3 study who achieved clinical remission at one year maintained long-t...

 eli-lilly-eyes-india-for-manufacturing-plans-to-spend-1-billion

Eli Lilly plans over $1 billion investment in India to expand drug manufacturing, partnerships, and a new Hyderabad facility.

 eli-lilly-commits-over-1b-to-india-for-drug-manufacturing-and-a-new-quality-center-in-hyderabad

-Reuters

 wall-street-hits-record-highs-as-rate-cut-bets-offset-shutdown-this-week-in-markets

S&P500, Nasdaq100, Dow Jones, and Russell 2000 all hit record highs as investors focus on corporate optimism, monetary easi...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION